# avoMD

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/avomd

- Industry: Healthcare IT
- Headquarters: New York, US
- Website: www.avomd.com
- Total disclosed funding: $18M
- Latest round: Series A (Mar 31, 2026)
- Investors on record: 9

## About

Based in New York, US, and founded in 2020, avoMD develops a no-code platform for interactive clinical pathways and decision support. The company was co-founded by Executive Chairman Dr. Joonghuem Park, CEO Dr. Yair Saperstein, and COO Mr. Laurence Coman.In April 2026, avoMD, Inc. raised USD 10 million in series A funding led by Noro-Moseley Partners, with participation from Scrub Capital, AlleyCorp, Las Olas Venture Capital, MedMountain Ventures, and Epsilon Health Investors.

AvoMD generates revenue by providing enterprise healthcare organizations with access to its EHR-integrated artificial intelligence platform that enables the deployment of clinical decision-support and workflow automation tools. The company’s platform is positioned as a B2B software solution for healthcare systems and provider organizations, supporting initiatives such as clinical guideline digitization, documentation improvement, and operational efficiency at the point of care.
avoMD offers a Point of Care App that provides the increases the usage of evidence-based guidelines, enhances and standardizes care, and provides educational support for their clinicians, the avoBuilder is the platform that allows you to create, edit, and distribute custom clinical content for the department, and hospital, and the Preoperative Evaluation provides quick, interactive, and educational guidance to help clinicians evaluate and prepare adult patients for noncardiac surgery.The March 2026, Funding capital will accelerate Avo’s path to becoming the leading AI platform for healthcare enterprises looking to drive their most pressing initiatives at the point of care

## Funding rounds

- Series A, Mar 31, 2026, $10M — Noro-Moseley Partners, AlleyCorp, Epsilon Health Investors, MedMountain Ventures, Las Olas Venture Capital, Scrub Capital
- Seed, Dec 23, 2022, $8.2M — Mirae Asset Global Investments, Dunamu & Partners, AlleyCorp, Epsilon Health Investors, MedMountain Ventures, Las Olas Capital Advisors

## Investors

- Mirae Asset Global Investments (https://capitalatlas.ai/funds/mirae-asset-global-investments) — Seed
- Dunamu & Partners (https://capitalatlas.ai/funds/dunamu-partners) — Seed
- AlleyCorp — Seed, Series A
- Epsilon Health Investors (https://capitalatlas.ai/funds/epsilon-health-investors) — Seed, Series A
- MedMountain Ventures (https://capitalatlas.ai/funds/medmountain-ventures) — Seed, Series A
- Las Olas Capital Advisors (https://capitalatlas.ai/funds/las-olas-capital-advisors) — Seed
- Noro-Moseley Partners (https://capitalatlas.ai/funds/noro-moseley-partners) — Series A
- Las Olas Venture Capital — Series A
- Scrub Capital (https://capitalatlas.ai/funds/scrub-capital) — Series A